Best Buy's Profit Plunges Amid Health Unit Impairment, Inventory Swells

TL;DR

**Best Buy's health bet is failing, dragging down profits and leaving them with a mountain of inventory; sell before the holiday hangover hits.**

AI Summary

Best Buy Co., Inc. (BBY) reported a significant decline in net earnings for the three and nine months ended November 1, 2025, despite a modest increase in revenue. For the three months, revenue rose to $9,672 million from $9,445 million in the prior year, but net earnings plummeted to $140 million from $273 million, a 48.7% decrease. Diluted earnings per share fell from $1.26 to $0.66. Over the nine-month period, revenue increased slightly to $27,877 million from $27,580 million, while net earnings dropped to $528 million from $810 million, a 34.8% decline. The company incurred substantial restructuring charges of $218 million for the nine months, up from $4 million, and a goodwill impairment of $171 million, primarily within its Best Buy Health reporting unit due to downward revisions in revenue growth and margin rates, particularly in the Medicaid and Medicare Advantage markets. Merchandise inventories increased significantly to $7,993 million as of November 1, 2025, from $5,085 million at February 1, 2025, indicating potential inventory management challenges or anticipation of holiday sales. Cash and cash equivalents decreased to $923 million from $1,578 million over the same period.

Why It Matters

This filing reveals significant operational headwinds for Best Buy, particularly the substantial goodwill impairment in its Best Buy Health segment, signaling challenges in its diversification strategy. For investors, the sharp decline in net earnings and diluted EPS, coupled with increased inventory levels, suggests potential margin pressure and a less optimistic outlook for future profitability, especially heading into the crucial holiday season. Employees in the Best Buy Health division may face further uncertainty following the optimization initiatives. Customers could see shifts in product offerings or service models as the company realigns its strategy. Competitively, this indicates that Best Buy is struggling to gain traction in new markets like health tech, while traditional retail faces ongoing pressures, potentially benefiting competitors with stronger digital or specialized offerings.

Risk Assessment

Risk Level: high — The risk level is high due to a 48.7% decrease in net earnings for the three months ended November 1, 2025, and a 34.8% decrease for the nine months, alongside a significant goodwill impairment of $171 million. Merchandise inventories surged to $7,993 million from $5,085 million in nine months, indicating potential overstocking or slowing sales, which could lead to future markdowns and further margin erosion.

Analyst Insight

Investors should consider reducing exposure to BBY given the substantial profit decline and goodwill impairment in a key growth area like Best Buy Health. Monitor inventory levels closely in the next quarter, as sustained high levels could signal deeper demand issues and further pressure on profitability. Re-evaluate the company's long-term growth strategy, especially its ability to diversify beyond traditional electronics retail.

Financial Highlights

debt To Equity

0.43

revenue

$9,672 million

operating Margin

2.05%

total Assets

$16,786 million

total Debt

$1,165 million

net Income

$140 million

eps

$0.66

gross Margin

23.24%

cash Position

$923 million

revenue Growth

+2.4%

Key Numbers

• $9,672 million — Revenue (3 months ended Nov 1, 2025) (Increased from $9,445 million in prior year)
• $140 million — Net earnings (3 months ended Nov 1, 2025) (Decreased from $273 million in prior year)
• $0.66 — Diluted EPS (3 months ended Nov 1, 2025) (Decreased from $1.26 in prior year)
• $27,877 million — Revenue (9 months ended Nov 1, 2025) (Increased from $27,580 million in prior year)
• $528 million — Net earnings (9 months ended Nov 1, 2025) (Decreased from $810 million in prior year)
• $218 million — Restructuring charges (9 months ended Nov 1, 2025) (Increased from $4 million in prior year)
• $171 million — Goodwill and intangible asset impairments (9 months ended Nov 1, 2025) (New charge, none in prior year)
• $7,993 million — Merchandise inventories (as of Nov 1, 2025) (Increased from $5,085 million as of Feb 1, 2025)
• $923 million — Cash and cash equivalents (as of Nov 1, 2025) (Decreased from $1,578 million as of Feb 1, 2025)
• 209,535,103 — Common shares outstanding (as of Dec 3, 2025) (Current outstanding shares)

Key Players & Entities

• BEST BUY CO INC (company) — registrant
• President Trump (person) — signed the OB3 Act
• New York Stock Exchange (regulator) — exchange where BBY is registered
• SEC (regulator) — filing recipient
• FASB (regulator) — issued accounting standards
• Best Buy Health (company) — reporting unit with goodwill impairment
• Medicaid (other) — market facing pressures for Best Buy Health
• Medicare Advantage (other) — market facing pressures for Best Buy Health
• Bloomberg (company) — publisher

FAQ

Risk Factors

• Goodwill Impairment in Best Buy Health [medium — financial]: A goodwill impairment of $171 million was recognized for the nine months ended November 1, 2025, primarily within the Best Buy Health reporting unit. This impairment was driven by downward revisions in revenue growth and margin rate expectations, particularly impacting the Medicaid and Medicare Advantage markets.
• Significant Inventory Increase [medium — operational]: Merchandise inventories surged to $7,993 million as of November 1, 2025, from $5,085 million at February 1, 2025. This substantial increase of over 57% could indicate potential inventory management challenges or an aggressive build-up for anticipated holiday sales, posing risks if demand does not meet expectations.
• Increased Restructuring Charges [high — operational]: Restructuring charges rose dramatically to $218 million for the nine months ended November 1, 2025, compared to only $4 million in the prior year. This indicates significant ongoing or planned operational adjustments that could impact future profitability and operational efficiency.
• Declining Profitability Despite Revenue Growth [high — financial]: Net earnings for the three months ended November 1, 2025, fell by 48.7% to $140 million from $273 million, while revenue saw a modest increase to $9,672 million. For the nine-month period, net earnings decreased by 34.8% to $528 million despite a slight revenue increase to $27,877 million, signaling margin compression or increased operating costs.
• Reduced Cash Position [medium — financial]: Cash and cash equivalents decreased to $923 million as of November 1, 2025, from $1,578 million as of February 1, 2025. This 41.5% reduction in liquidity could constrain the company's ability to fund operations, investments, or manage unexpected financial needs.

Industry Context

Best Buy operates in the highly competitive consumer electronics retail sector, facing pressure from online retailers, big-box stores, and direct-to-consumer brands. The industry is characterized by rapid technological advancements, cyclical consumer spending, and evolving shopping habits, with a growing emphasis on omnichannel experiences and services.

Regulatory Implications

While this filing does not highlight specific new regulatory changes, Best Buy, like all large retailers, is subject to consumer protection laws, data privacy regulations (e.g., CCPA, GDPR), and environmental regulations concerning product disposal and energy efficiency. Compliance with these evolving standards is crucial to avoid fines and maintain customer trust.

What Investors Should Do

1. [object Object]
2. [object Object]
3. [object Object]
4. [object Object]

Key Dates

• 2025-11-01: End of Third Quarter 2025 Fiscal Period — Reporting period for the 10-Q, showing declining net earnings despite modest revenue growth and significant restructuring/impairment charges.
• 2025-02-01: End of Fourth Quarter 2024 Fiscal Period — Comparative balance sheet date, showing a lower inventory level and higher cash position than the current period.
• 2024-11-02: End of Third Quarter 2024 Fiscal Period — Prior year comparative period for the condensed statements of earnings, highlighting a significant drop in net earnings and EPS for the current year.

Glossary

Goodwill and intangible asset impairments

A charge taken when the carrying value of goodwill or other intangible assets on the balance sheet is deemed to be higher than their fair value, indicating a loss in value. (A significant $171 million impairment charge was recorded, impacting net earnings and reflecting a decline in the value of the Best Buy Health reporting unit.)

Restructuring charges

Costs associated with significant reorganizations, such as layoffs, facility closures, or business unit divestitures. (A substantial increase to $218 million in the nine-month period indicates significant ongoing or planned operational changes impacting profitability.)

Merchandise inventories

The cost of goods that a retailer has on hand and intends to sell. (A large increase to $7,993 million suggests potential inventory management issues or a strategic build-up, impacting working capital and potential obsolescence risk.)

Diluted earnings per share (EPS)

A measure of a company's profit allocated to each outstanding share of common stock, assuming all convertible securities and stock options were exercised. (The significant decrease from $1.26 to $0.66 for the three-month period reflects the sharp decline in net earnings.)

Cash and cash equivalents

Highly liquid investments that are readily convertible to known amounts of cash and which are so near their maturity that they present an insignificant risk of changes in value. (The decrease to $923 million indicates a reduction in the company's immediate liquidity.)

Year-Over-Year Comparison

Compared to the prior year's comparable periods, Best Buy Co., Inc. has experienced a notable decline in profitability. For the three months ended November 1, 2025, net earnings dropped by 48.7% to $140 million, and diluted EPS fell from $1.26 to $0.66, despite a modest revenue increase. The nine-month period shows a similar trend with net earnings down 34.8% to $528 million. This is exacerbated by a significant increase in restructuring charges to $218 million and a new goodwill impairment of $171 million, while merchandise inventories have risen substantially and cash reserves have decreased.

Key Financial Figures

• $0.10 — ange on which registered Common Stock, $0.10 par value per share BBY New York Stock

Filing Documents

• bby-20251101.htm (10-Q) — 1229KB
• bby-fy26q3x10xqexx311.htm (EX-31.1) — 9KB
• bby-fy26q3x10xqexx312.htm (EX-31.2) — 10KB
• bby-fy26q3x10xqexx321.htm (EX-32.1) — 4KB
• bby-fy26q3x10xqexx322.htm (EX-32.2) — 5KB
• bby-20251101_g1.jpg (GRAPHIC) — 34KB
• 0000764478-25-000057.txt ( ) — 6425KB
• bby-20251101.xsd (EX-101.SCH) — 39KB
• bby-20251101_cal.xml (EX-101.CAL) — 56KB
• bby-20251101_def.xml (EX-101.DEF) — 198KB
• bby-20251101_lab.xml (EX-101.LAB) — 477KB
• bby-20251101_pre.xml (EX-101.PRE) — 366KB
• bby-20251101_htm.xml (XML) — 1090KB

— Financial Information

Part I — Financial Information 3 Item 1.

Financial Statements

Financial Statements 3 a) Condensed Consolidated Balance Sheets as of Novem be r 1 , 2025, February 1, 2025, and November 2 , 2024 3 b) Condensed Consolidated Statements of Earnings for the three and nine months ended November 1 , 2025, and November 2 , 2024 4 c) Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended November 1 , 2025, and November 2 , 2024 5 d) Condensed Consolidated Statements of Cash Flows for the nine months ended November 1 , 2025, and November 2 , 2024 6 e) Condensed Consolidated Statements of Changes in Shareholders' Equity for the three and nine months ended November 1 , 2025, and November 2 , 2024 7 f) Notes to Condensed Consolidated Financial Statements 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 18 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 29 Item 4.

Controls and Procedures

Controls and Procedures 29

— Other Information

Part II — Other Information 30 Item 1.

Legal Proceedings

Legal Proceedings 30 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 30 Item 5. Other Information 30 Item 6. Exhibits 30

Signatures

Signatures 31 WEBSITE AND SOCIAL MEDIA DISCLOSURE We disclose information to the public concerning Best Buy, Best Buy's products, content and services and other items through our websites in order to achieve broad, non-exclusionary distribution of information to the public. Some of the information distributed through this channel may be considered material information. Investors and others are encouraged to review the information we make public in the locations below.* This list may be updated from time to time. For information concerning Best Buy and its products, content and services, please visit: https://bestbuy.com. For information provided to the investment community, including news releases, events and presentations, and filings with the SEC, please visit: https://investors.bestbuy.com. For the latest information from Best Buy, including press releases, please visit: https://corporate.bestbuy.com/archive/. * These corporate websites, and the contents thereof, are not incorporated by reference into this Quarterly Report on Form 10-Q nor deemed filed with the SEC. 2 Table of Contents

— FINANCIAL INFORMATION

PART I — FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements Condensed Consolidated Balance Sheets $ in millions, except per share amounts (unaudited) November 1, 2025 February 1, 2025 November 2, 2024 Assets Current assets Cash and cash equivalents $ 923 $ 1,578 $ 643 Receivables, net 1,017 1,044 932 Merchandise inventories 7,993 5,085 7,806 Other current assets 640 517 574 Total current assets 10,573 8,224 9,955 Property and equipment, net 2,037 2,122 2,196 Operating lease assets 2,838 2,833 2,842 Goodwill 790 908 1,383 Other assets 548 695 642 Total assets $ 16,786 $ 14,782 $ 17,018 Liabilities and equity Current liabilities Accounts payable $ 7,319 $ 4,980 $ 7,145 Unredeemed gift card liabilities 231 253 246 Deferred revenue 853 951 878 Accrued compensation and related expenses 392 464 361 Accrued liabilities 689 741 690 Current portion of operating lease liabilities 619 617 616 Current portion of long-term debt 10 10 12 Total current liabilities 10,113 8,016 9,948 Long-term operating lease liabilities 2,309 2,282 2,293 Long-term debt 1,155 1,144 1,144 Long-term liabilities 556 532 551 Contingencies (Note 10) Equity Best Buy Co., Inc. Shareholders' Equity Preferred stock, $ 1.00 par value: Authorized - 400,000 shares; Issued and outstanding - none - - - Common stock, $ 0.10 par value: Authorized - 1.0 billion shares; Issued and outstanding - 210.0 million, 211.4 million and 213.8 million shares, respectively 22 22 22 Additional paid-in capital 16 - - Retained earnings 2,306 2,486 2,751 Accumulated other comprehensive income 309 300 309 Total equity 2,653 2,808 3,082 Total liabilities and equity $ 16,786 $ 14,782 $ 17,018 NOTE: The Consolidated Balance Sheet as of February 1, 2025, has been condensed from the audited consolidated financial statements. See Notes to Condensed Consolidated Financial Statements. 3 Table of Contents Condensed Consolidated Statements of Earnings $ and shares in millions, except per share amounts (unaudited) Three